Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
Dafna Ben Bashat et al. Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease NPJ Parkinson’s Disease. Publication Date October 21, 2022 How Analyze was Used “Preprocessing included calculation of the T2* maps from the 3D gradient multi echo sequence based on the method proposed by ref. 49. The neuromelanin…